CGTX - Cognition Therapeutics GAAP EPS of -$0.29 beats by $0.09 November, 14 2022 09:20 AM Cognition Therapeutics Inc. Cognition Therapeutics press release ( NASDAQ: CGTX ): Q3 GAAP EPS of -$0.29 beats by $0.09 . Cash and cash equivalents at September 30, 2022 were approximately $46.6 million. For further details see: Cognition Therapeutics GAAP EPS of -$0.29 beats by $0.09